Recently, we showed that upregulation of P4HB was associated with temozolomide (TMZ) resistance in malignant glioma, and that its inhibition may sensitize chemoresistant glioma to TMZ treatment [16]. This evidence concerns the gene P4HB and central nervous system cancer.